Eprosartan Mesylate (SKF-108566J) is a potent and nonpeptide angiotensin II receptor antagonist with IC50 of 9.2 and 3.9 nM in rat and human adrenal cortical membranes, respectively.

Benazepril HCl (formerly CGS 14824A; CGS-14824-A; Briem; Cibacène; Cibacen; Labopal; Lotensin), the hydrochloride salt of Benazepril which is a prodrug that can be metabolized to its active form benazeprilat, is a potent angiotensin I converting enzyme (ACE) inhibitor that has been widely used primarily in treatment of hypertension.

Temocapril (CS-622; CS622; temocaprilum; Aceco) is a potent and long-acting angiotensin-converting enzyme (ACE) inhibitor, approved for use (not in the USA) in the treatment of hypertension.=

Imidapril HCl (TA-6366; TA-6366; Tanatril), the hydrochloride salt of imidapril, is a potent angiotensin-converting enzyme (ACE) inhibitor with IC50 of 2.6 nM, approved in 1993 for use as an antihypertensive drug and for the treatment of chronic heart failure.

Cilazapril Monohydrate (Ro 31-2848) is a potent angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure.

Enalaprilat Dihydrate (also known as MK422; MK 422; MK-422; Epaned, Vasotec, Vasotec IV), the active metabolite of enalapril, is an angiotensin-converting enzyme (ACE) inhibitor approved for the treatment of hypertension, diabetic nephropathy, and chronic heart failure.

Temocapril HCl is the hydrochloride of Temocapril, which is a long-acting angiotensin-converting enzyme (ACE) inhibitor, it is used for the treatment of hypertension.

Valsartan (formerly CGP-48933; CGP48933; Diovan, Prova, Tareg, Miten, Nisis, Vals, Walsarta), an approved antihypertensive drug, is a potent and selective angiotensin II receptor antagonist that is used for the treatment of high blood pressure and congestive heart failure.

Azilsartan (TAK-536; TAK536; Edarbi; Ipreziv) is a potent and orally bioavailable angiotensin II type 1 (AT1) receptor antagonist with antihypertensive effects.

Aliskiren hemifumarate (CGP-60536; CGP60536; Rasilez; SPP100; SPP-100; Tekturna), the hemifumarate salt form of Aliskiren, is a potent and direct renin inhibitor with antihypertensive activity.